Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 2
1988 1
1991 1
1992 1
1993 1
1994 2
1995 3
1996 5
1997 2
1998 3
1999 2
2000 2
2001 5
2002 3
2003 5
2004 4
2005 3
2006 1
2007 6
2008 4
2009 4
2010 8
2011 9
2012 3
2013 5
2014 6
2015 4
2016 9
2017 6
2018 10
2019 11
2020 5
2021 15
2022 18
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection"
Page 1
Varicella zoster virus infection.
Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, Grose C, Hambleton S, Kennedy PG, Oxman MN, Seward JF, Yamanishi K. Gershon AA, et al. Nat Rev Dis Primers. 2015 Jul 2;1:15016. doi: 10.1038/nrdp.2015.16. Nat Rev Dis Primers. 2015. PMID: 27188665 Free PMC article. Review.
Primary infection is followed by latency in ganglionic neurons. During this period, no virus particles are produced and no obvious neuronal damage occurs. ...In this Primer we discuss the pathogenesis, diagnosis, treatment, and prevention of VZV infections, w …
Primary infection is followed by latency in ganglionic neurons. During this period, no virus particles are produced and no obv …
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Gray GE, Bekker LG, Laher F, Malahleha M, Allen M, Moodie Z, Grunenberg N, Huang Y, Grove D, Prigmore B, Kee JJ, Benkeser D, Hural J, Innes C, Lazarus E, Meintjes G, Naicker N, Kalonji D, Nchabeleng M, Sebe M, Singh N, Kotze P, Kassim S, Dubula T, Naicker V, Brumskine W, Ncayiya CN, Ward AM, Garrett N, Kistnasami G, Gaffoor Z, Selepe P, Makhoba PB, Mathebula MP, Mda P, Adonis T, Mapetla KS, Modibedi B, Philip T, Kobane G, Bentley C, Ramirez S, Takuva S, Jones M, Sikhosana M, Atujuna M, Andrasik M, Hejazi NS, Puren A, Wiesner L, Phogat S, Diaz Granados C, Koutsoukos M, Van Der Meeren O, Barnett SW, Kanesa-Thasan N, Kublin JG, McElrath MJ, Gilbert PB, Janes H, Corey L; HVTN 702 Study Team. Gray GE, et al. N Engl J Med. 2021 Mar 25;384(12):1089-1100. doi: 10.1056/NEJMoa2031499. N Engl J Med. 2021. PMID: 33761206 Free PMC article. Clinical Trial.
BACKGROUND: A safe, effective vaccine is essential to eradicating human immunodeficiency virus (HIV) infection. ...The primary efficacy outcome was the occurrence of HIV-1 infection from randomization to 24 months. ...
BACKGROUND: A safe, effective vaccine is essential to eradicating human immunodeficiency virus (HIV) infection. ...The …
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Cottle L, Zhang XC, Makhema J, Mills LA, Panchia R, Faesen S, Eron J, Gallant J, Havlir D, Swindells S, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano DD, Essex M, Hudelson SE, Redd AD, Fleming TR; HPTN 052 Study Team. Cohen MS, et al. N Engl J Med. 2016 Sep 1;375(9):830-9. doi: 10.1056/NEJMoa1600693. Epub 2016 Jul 18. N Engl J Med. 2016. PMID: 27424812 Free PMC article. Clinical Trial.
Viral-linkage status was determined for 72 (92%) of the partner infections. ...No linked infections were observed when HIV-1 infection was stably suppressed by ART in the index participant. ...
Viral-linkage status was determined for 72 (92%) of the partner infections. ...No linked infections were observed when …
Advances in clinical outcomes: What we have learned during the COVID-19 pandemic.
Al-Musa A, LaBere B, Habiballah S, Nguyen AA, Chou J. Al-Musa A, et al. J Allergy Clin Immunol. 2022 Feb;149(2):569-578. doi: 10.1016/j.jaci.2021.12.775. Epub 2021 Dec 24. J Allergy Clin Immunol. 2022. PMID: 34958811 Free PMC article. Review.
Epidemiologic studies have shown that asthma control, rather than a diagnosis of asthma, is a determinant of COVID-19 severity. Clinical outcomes in patients with primary immunodeficiencies, even in those with impaired cellular immunity, are variable. ...Studies of genetic …
Epidemiologic studies have shown that asthma control, rather than a diagnosis of asthma, is a determinant of COVID-19 severity. Clinical out …
Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure.
Ventura JD. Ventura JD. Yale J Biol Med. 2020 Sep 30;93(4):549-560. eCollection 2020 Sep. Yale J Biol Med. 2020. PMID: 33005119 Free PMC article. Review.
An estimated 37 million people globally suffer from Human Immunodeficiency Virus-1 (HIV-1) infection with 1.7 million newly acquired infections occurring on average each year. Although crucial advances in combined antiretroviral therapy (ART) over the last tw …
An estimated 37 million people globally suffer from Human Immunodeficiency Virus-1 (HIV-1) infection with 1.7 million newly ac …
Benefit-risk evaluation of COVID-19 vaccination in special population groups of interest.
Moss P, Berenbaum F, Curigliano G, Grupper A, Berg T, Pather S. Moss P, et al. Vaccine. 2022 Jul 30;40(32):4348-4360. doi: 10.1016/j.vaccine.2022.05.067. Epub 2022 May 27. Vaccine. 2022. PMID: 35718592 Free PMC article. Review.
Several population groups display an increased risk of severe disease and mortality following SARS-CoV-2 infection. These include those who are immunocompromised (IC), have a cancer diagnosis, human immunodeficiency virus (HIV) infection or chronic inflammato …
Several population groups display an increased risk of severe disease and mortality following SARS-CoV-2 infection. These include tho …
Functional CVIDs phenotype clusters identified by the integration of immune parameters after BNT162b2 boosters.
Piano Mortari E, Pulvirenti F, Marcellini V, Terreri S, Salinas AF, Ferrari S, Di Napoli G, Guadagnolo D, Sculco E, Albano C, Guercio M, Di Cecca S, Milito C, Garzi G, Pesce AM, Bonanni L, Sinibaldi M, Bordoni V, Di Cecilia S, Accordini S, Castilletti C, Agrati C, Quintarelli C, Zaffina S, Locatelli F, Carsetti R, Quinti I. Piano Mortari E, et al. Front Immunol. 2023 May 25;14:1194225. doi: 10.3389/fimmu.2023.1194225. eCollection 2023. Front Immunol. 2023. PMID: 37304298 Free PMC article.
METHODS: We performed a longitudinal study on 47 CVIDs patients who received the 3rd and 4th vaccine dose of the BNT162b2 vaccine measuring the generation of immunological memory. ...DISCUSSION: Thanks to the integration of our data, we identified four functional gr …
METHODS: We performed a longitudinal study on 47 CVIDs patients who received the 3rd and 4th vaccine dose of the BNT162b2 vaccine …
Newborn screening for severe combined immunodeficiency-Coming to a region near you soon.
Elliman DAC, Gennery AR. Elliman DAC, et al. Clin Exp Immunol. 2021 Sep;205(3):343-345. doi: 10.1111/cei.13642. Epub 2021 Jul 8. Clin Exp Immunol. 2021. PMID: 34235744 Free PMC article.
The most profound of primary immunodeficiencies, severe combined immunodeficiency (SCID), presents in infancy. Infants appear healthy at birth, but they are unable to clear pathogens, particularly viruses, and present with recurrent infection, progressive pnu …
The most profound of primary immunodeficiencies, severe combined immunodeficiency (SCID), presents in infancy. Infants appear …
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India.
Mohanty MC, Madkaikar MR, Desai M, Taur P, Nalavade UP, Sharma DK, Gupta M, Dalvi A, Shabrish S, Kulkarni M, Aluri J, Deshpande JM. Mohanty MC, et al. Emerg Infect Dis. 2017 Oct;23(10):1664-1670. doi: 10.3201/eid2310.170724. Emerg Infect Dis. 2017. PMID: 28930011 Free PMC article.
During September 2014-April 2017, 151 patients received diagnoses of primary immunodeficiency (PID). We isolated 8 enteroviruses (3 polioviruses and 5 nonpolio enteroviruses) in cell culture of 105 fecal samples collected from 42 patients. Only 1 patient with severe …
During September 2014-April 2017, 151 patients received diagnoses of primary immunodeficiency (PID). We isolated 8 enterovirus …
Cellular immune response to SARS-CoV-2 in patients with primary antibody deficiencies.
Mizera D, Dziedzic R, Drynda A, Gradzikiewicz A, Jakieła B, Celińska-Löwenhoff M, Padjas A, Matyja-Bednarczyk A, Zaręba L, Bazan-Socha S. Mizera D, et al. Front Immunol. 2023 Oct 12;14:1275892. doi: 10.3389/fimmu.2023.1275892. eCollection 2023. Front Immunol. 2023. PMID: 37901210 Free PMC article.
INTRODUCTION: Primary antibody deficiencies (PAD) are inborn defects of the immune system that result in increased susceptibility to infections. Despite the reduced response to vaccination, PAD patients still benefit from it by reducing the risk of severe infecti …
INTRODUCTION: Primary antibody deficiencies (PAD) are inborn defects of the immune system that result in increased susceptibility to …
172 results